Dual agonist comes up often in conversation and rarely with the context attached. Here we lay out the basics in order, then work through the practical considerations.
Updated 2025-12-31. Numbers and descriptions here follow the published literature rather than marketing material.
Tirzepatide is a synthetic peptide built from thirty-nine amino acids. Its sequence is derived from native glucose-dependent insulinotropic polypeptide, or GIP, with several non-natural residues and a fatty diacid side chain attached through a linker. The molecule behaves as a dual agonist at two incretin receptors, GIP and GLP-1, instead of targeting a single receptor. This dual engagement separates it from earlier single-receptor incretin compounds and underpins most of its reported pharmacological activity.
At the receptor level, the compound binds both GIP and GLP-1 receptors and triggers downstream signalling that raises cyclic AMP in target cells. GLP-1 receptor activation is associated with glucose-dependent insulin release, slower gastric emptying, and reduced appetite signalling. GIP receptor activation contributes effects that are less completely characterised, and how much each receptor adds to the overall clinical response is still an open question. The two pathways appear to interact in a complementary rather than a purely additive way.
固体状态的 tirzepatide 通常以冻干粉形式保存，推荐在低温、避光、干燥条件下存放，常见区间为 2 至 8 摄氏度，长期保存可考虑更低温度并避免反复冻融。冻融循环会导致肽链聚集或析出，从而影响后续定量结果。容器密封性与湿度控制同样是稳定性研究中反复强调的因素。
溶解操作一般使用注射用水或适宜的水性缓冲液，必要时加入少量助溶剂以改善溶解速度，但应避免剧烈涡旋振荡，因为剪切力可能促进聚集。配制后的溶液在冷藏条件下的稳定时间通常短于固体形态，具体时限取决于浓度、缓冲体系与容器材质。是否加入防腐成分，则取决于用途是否为多次取样。
| Property | Value | Notes |
|---|---|---|
| Molecular formula | C225H348N48O68 | Free base form |
| Molecular mass | Approximately 4813 Da | Calculated from the sequence |
| Amino acid residues | 39 | GIP-derived backbone |
| Receptor targets | GIP and GLP-1 | Dual agonist |
| Circulating half-life | About 5 days | Supports weekly administration |
Tirzepatide is a synthetic peptide built from 39 amino acid residues. Its backbone derives from the native glucose-dependent insulinotropic polypeptide sequence, altered at several positions to resist enzymatic cleavage. A fatty diacid group attached through a linker extends plasma residence time by promoting reversible binding to serum albumin. The molecule carries a net negative charge near physiological pH and has a reported molecular weight close to 4813 daltons. These features separate it from shorter incretin analogs and account for its prolonged dosing interval.
Pharmacologically, tirzepatide activates two distinct G protein-coupled receptors: the glucose-dependent insulinotropic polypeptide receptor and the glucagon-like peptide-1 receptor. Binding at each target triggers cyclic AMP accumulation and downstream signaling in pancreatic beta cells, adipose tissue and the central nervous system. Because the two pathways overlap only partially, the combined effect on insulin secretion, glucagon suppression and appetite signaling differs from that of selective single-receptor compounds. Affinity is not equal across the two targets, and the clinical meaning of that imbalance remains an area of active study.
Dual agonism at the GIP and GLP-1 receptors underlies the observed pharmacology. Activation of GLP-1 receptors raises glucose-dependent insulin release, lowers glucagon secretion, slows gastric emptying and reduces appetite. GIP receptor activation contributes additional effects on adipose tissue and on energy balance, and the combined action on appetite appears larger than either pathway alone in animal models. Signalling bias and the relative contribution of each receptor arm to weight-related effects remain areas of active investigation.
Structure-activity work shows that fatty acid length, linker chemistry and the position of acylation all influence albumin affinity and receptor potency. Plasma protein binding exceeds 99 percent, which restricts distribution and slows renal clearance. Degradation proceeds largely through general proteolysis and fatty acid oxidation rather than cytochrome P450 metabolism, so exposure to common oxidative drug interactions is limited. Whether these clearance routes vary meaningfully between individuals is not fully established.
A wide range of potential structures have been reported. These all feature the classical organophosphorus core (sometimes with the P=O replaced with P=S or P=Se), which is most commonly depicted as being a phosphoramidate or phosphonate, usually fluorinated (cf. monofluorophosphate). The organic groups are subject to more variety; however, a common substituent is phosgene oxime or analogues thereof. This is a potent chemical weapon in its own right, specifically as a nettle agent, and would be expected to increase the harm done by the Novichok agent. Many claimed structures from this group also contain cross-linking agent motifs which may covalently bind to the acetylcholinesterase enzyme's active site in several places, perhaps explaining the rapid denaturing of the enzyme that is claimed to be characteristic of the Novichok agents. Zoran Radić, a chemist at the University of California, San Diego, performed an in silico docking study with Mirzayanov's version of the A-232 structure against the active site of the acetylcholinesterase enzyme. The model predicted a tight fit with high binding affinity and formation of a covalent bond to a serine residue in the active site, with a similar binding mode to established nerve agents such as sarin and soman.
Containerization (1956): The container ship Ideal X sailed in April 1956 carrying standardized containers, a milestone that helped cut loading time and supported the rise of modern global supply chains. Cash-and-carry wholesale (1960s): The launch of METRO Cash & Carry in 1964 in Germany as a model where professional customers selected goods under one roof, paid, and took items directly, a format that spread internationally. Distribution centers (early 1970s): Walmart's first distribution center and home office opened in Bentonville, Arkansas in 1971, reflecting the broader shift toward centralized warehousing and controlled replenishment. Barcodes (1974): Multiple credible historical sources report that the first UPC scan occurred on June 26, 1974, at a Marsh supermarket in Troy, Ohio, using a pack of Wrigley's gum, helping enable faster receiving, inventory control, and checkout across supply chains. As supply chains scaled, businesses invested in electronic document exchange. EDI is widely described as a way to replace paper documents (such as purchase orders and invoices) with standardized electronic messages, with origins traced back to the 1960s and wider adoption later.
Interpreting pet food labels – Pet food labeling according to AAFCO regulations National Research Council (U.S.). Subcommittee on Dog Nutrition (1974). Nutrient requirements of dogs. National Academy of Sciences. ISBN 978-0-309-02315-3.
Sources: en.wikipedia.org
{\displaystyle {\frac {\omega }{k}}=\left[{\frac {1}{2}}\left(v_{\text{A}}^{2}+v_{\text{s}}^{2}\pm {\sqrt {\left(v_{\text{A}}^{2}+v_{\text{s}}^{2}\right)^{2}-4v_{\text{s}}^{2}v_{\text{A}}^{2}\cos ^{2}\theta }}\right)\right]^{1/2}}
Despite many advantages that the concept of hypercycles presents, there were also some problems regarding the traditional model formulation using ODEs: a vulnerability to parasites and a limited size of stable hypercycles. In 2012, the first experimental proof for the emergence of a cooperative network among fragments of self-assembling ribozymes was published, demonstrating their advantages over self-replicating cycles. However, even though this experiment proves the existence of cooperation among the recombinase ribozyme subnetworks, this cooperative network does not form a hypercycle per se, so we still lack the experimental demonstration of hypercycles.
=== Fibers === Surface energy values obtained by IGC have been used extensively on fibrous materials including textiles, natural fibers, glass fibers, and carbon fibers. Most of these and other related studies investigating the surface energy of fibers are focusing on the use of these fibers in composites. Ultimately, the changes in surface energy can be related to composite performance via the works of adhesion and cohesion discussed previously.
Sources: en.wikipedia.org
It acts as a dual agonist at the GIP receptor and the GLP-1 receptor. This broader targeting profile distinguishes it from selective GLP-1 agonists, which engage only one receptor.
A fatty diacid side chain promotes binding to albumin, which delays clearance from circulation. The half-life of roughly five days makes a weekly schedule practical.
No. It is a synthetic peptide whose backbone is based on the natural incretin hormone GIP. Non-natural residues and the lipid side chain were engineered to improve stability and duration of action.
建议在低温、避光、干燥环境中密封保存，常见条件为 2 至 8 摄氏度，长期存放可置于更低温度。应避免反复冻融，并尽量减少容器开启次数。